Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

295
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
295
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

220
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
220
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

287
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
287
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

387
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
387
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

185
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
185
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

881
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
881

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuberculosis in Poland in 2022.

Przeglad epidemiologiczny·2025
Same author

Tuberculosis in Poland in 2021.

Przeglad epidemiologiczny·2024
Same author

Inventory study on completeness of tuberculosis case notifications in Poland in 2018.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2024
Same author

Tuberculosis incidence in foreign-born people residing in European countries in 2020.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2023
Same author

Cladribine treatment in patients with pulmonary Langerhans cell histiocytosis.

Polish archives of internal medicine·2023
Same author

The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study.

Frontiers in public health·2023
Same journal

Infectious diseases in Poland in 2023.

Przeglad epidemiologiczny·2026
Same journal

Foodborne infections and intoxications in Poland in 2021-2023.

Przeglad epidemiologiczny·2026
Same journal

Salmonellosis in Poland in 2023.

Przeglad epidemiologiczny·2026
Same journal

Pertussis in Poland in 2023.

Przeglad epidemiologiczny·2026
Same journal

Lyme disease in Poland in 2023.

Przeglad epidemiologiczny·2026
Same journal

Tuberculosis in Poland in 2023.

Przeglad epidemiologiczny·2026
See all related articles

Related Experiment Video

Updated: Aug 4, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K

Tuberculosis in Poland in 2020.

Maria Korzeniewska-Koseła1, Stefan Wesołowski2

  • 1Department of Tuberculosis Epidemiology and Surveillance, National Tuberculosis and Lung Diseases Research Institute.

Przeglad Epidemiologiczny
|April 5, 2023
PubMed
Summary
This summary is machine-generated.

Tuberculosis (TB) incidence in Poland significantly decreased by 36.7% in 2020, a decline not seen in two decades. Poland also reported higher bacteriological confirmation rates and lower multidrug-resistant TB (MDR-TB) percentages compared to EU/EEA countries.

Keywords:
MDR-TBTB confirmed by cultureTB incidencetuberculosis (TB)

More Related Videos

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.1K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

300

Related Experiment Videos

Last Updated: Aug 4, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.1K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

300

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • Tuberculosis (TB) remains a significant global health challenge, necessitating ongoing surveillance and analysis of epidemiological trends.
  • Understanding the specific epidemiology of TB in Poland and its comparison with European Union/European Economic Area (EU/EEA) countries is crucial for targeted public health interventions.
  • The year 2020 presented unique circumstances potentially impacting disease patterns due to global events.

Purpose of the Study:

  • To evaluate the primary epidemiological features of tuberculosis (TB) in Poland during 2020.
  • To compare the TB situation in Poland with that of other European Union and European Economic Area (EU/EEA) countries.
  • To identify trends and variations in TB incidence, drug resistance, and demographic distribution within Poland.

Main Methods:

  • Analysis of case-based data from the National TB Register for 2020.
  • Inclusion of data on anti-TB drug susceptibility, mortality statistics from 2019, and information on HIV-positive individuals with TB.
  • Utilized data from the European Centre for Disease Prevention and Control and WHO reports for comparative analysis.

Main Results:

  • Poland reported 3,388 TB cases in 2020, with an incidence rate of 8.8 per 100,000 population, showing significant regional variability.
  • A notable 36.7% decrease in TB incidence was observed compared to 2019, the largest decline in two decades.
  • Pulmonary TB constituted 95.5% of cases, with bacteriological confirmation in 79.5% and multidrug-resistant TB (MDR-TB) in 1.6% of cases with known drug sensitivity.

Conclusions:

  • The substantial decrease in TB incidence in Poland in 2020 is a significant public health achievement.
  • Poland demonstrated higher bacteriological confirmation rates and a lower proportion of MDR-TB compared to EU/EEA averages.
  • Higher TB incidence was observed in older age groups and in men, with migration having a limited impact on the overall TB pattern in 2020.